# France Sleep Aids Market

> France Sleep Aids Market Research Report: Size, Share, Trend Analysis By Product (Mattresses & Pillows, Medications, Sleep Apnea Devices, Others) and By Sleep-Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking, Other Sleep Disorders) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.18%
- **2024:** $ 2,592.94 Million
- **2025:** $ 2,779.11 Million
- **2035:** $ 5,558 Million
- **Key Players:** Pfizer Inc (US), Johnson & Johnson (US), Sanofi (FR), Reckitt Benckiser Group plc (GB), Procter & Gamble Co (US), Sleep Number Corporation (US), ResMed Inc (US), Haleon plc (GB)

**Report ID:** MRFR/HC/50268-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/france-sleep-aids-market-52026

---

## Market Summary

## **France Sleep Aids Market Overview**

As per MRFR analysis, the France Sleep Aids Market Size was estimated at 3.48 (USD Billion) in 2023. The France Sleep Aids Market Industry is expected to grow from 3.73(USD Billion) in 2024 to 6.85 (USD Billion) by 2035. The France Sleep Aids Market CAGR (growth rate) is expected to be around 5.671% during the forecast period (2025 - 2035)

**Key France Sleep Aids Market Trends Highlighted**

The France Sleep Aids Market is witnessing notable trends driven by increasing awareness regarding sleep disorders and their impact on overall health. Factors like rising stress levels due to work demands and lifestyle changes contribute significantly to sleep-related issues in the French population. The government campaigns aimed at promoting sleep health have also encouraged individuals to seek solutions for improving their sleep quality. With organizations like the French Sleep Institute providing valuable information on the importance of sleep, there is a growing demand for various sleep aids, including over-the-counter medications, herbal solutions, and natural remedies.

Opportunities to be explored include the development of innovative products tailored to specific consumer needs, such as melatonin supplements or sleep-monitoring devices. The French market shows a trend towards natural and organic sleep aids, as consumers are increasingly inclined to opt for products perceived as healthier and less likely to have side effects. Retailers are responding to this shift by expanding their offerings to include more organic and herbal options.

Additionally, the integration of technology in sleep aid products, such as sleep tracking apps and smart sleep devices, indicates that consumers are looking for comprehensive solutions to manage their sleep more effectively.

Recent trends highlight a shift towards preventive healthcare in France, where individuals are taking proactive steps to improve their sleep patterns. There is increasing attention on mental health and its correlation with quality sleep, prompting more individuals to explore different sleep aids. The rise of telemedicine in France is also making it easier for consumers to access sleep consultation services, thereby broadening the scope of the sleep aids market. Overall, the France Sleep Aids Market is evolving, reflecting consumer preferences for effective, safe, and holistic sleep solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**France Sleep Aids Market Drivers**

**Increasing Prevalence of Sleep Disorders**

One of the main factors propelling the France sleep aids market is the rising prevalence of sleep disorders in the country. According to recent medical statistics, over 25% of French people experience sleep-related problems such as insomnia, sleep apnoea, and restless legs syndrome. The French National Institute for Health and Medical Research reports that during the past five years, the prevalence of sleep apnoea in particular has grown by around 10%, mostly as a result of changing lifestyles and growing obesity rates. 

The demand for a variety of sleep help items, including over-the-counter drugs, melatonin supplements, and sleep treatment equipment, is driven by this concerning trend. Additionally, groups like the French Society of Sleep Medicine are always pushing for improved knowledge and treatment of sleep problems, which directly propels market expansion as customers look for efficient ways to improve the quality of their sleep.

**Growing Interest in Natural Sleep Aids**

In recent years, there has been a marked shift in consumer preference towards natural and herbal sleep aids in France, with many individuals seeking non-pharmaceutical options to improve their sleep. Reports suggest that sales of herbal sleep supplements have risen by approximately 20% over the last three years, as consumers increasingly prefer products containing ingredients like valerian root and chamomile. 

This growing segment of the France Sleep Aids Market Industry is reinforced by local herbal medicine associations that provide education on the benefits of natural remedies.Additionally, the French government has implemented policies to promote the use of natural ingredients in health products, thus bolstering the market for natural sleep aids and aligning with consumer trends towards holistic health solutions.

**Rising Awareness of Sleep Hygiene**

The increasing awareness surrounding the importance of sleep hygiene in France also plays a crucial role in the growth of the France Sleep Aids Market Industry. Educational campaigns led by both private organizations and health authorities emphasize the significance of good sleep practices for overall well-being. Data indicates that more than 60% of the French population acknowledges the impacts of poor sleep hygiene on health, leading to a growing market for sleep aids that enhance sleep routines.

In response, companies are innovating products geared towards improving sleep environments, such as weighted blankets and sleep masks, thereby expanding their product lines to meet the heightened consumer demand for sleep improvement solutions. Moreover, the French Ministry of Health has promoted initiatives aimed at encouraging healthier sleep practices, thereby reinforcing consumer interest in sleep aids as essential tools for better sleep management.

**France Sleep Aids Market Segment Insights**

**Sleep Aids Market Product Insights**

The France Sleep Aids Market is experiencing significant growth in its Product segment, which encompasses a variety of offerings designed to enhance sleep quality. This segment includes an array of items such as mattresses and pillows, medications, sleep apnea devices, and other innovative solutions aimed at addressing sleep-related issues. The mattresses and pillows market represents a critical area, as comfort and support play essential roles in achieving restful sleep.

With an increasing awareness of sleep hygiene and its impact on overall health, the demand for ergonomically designed mattresses and pillows has surged.Sleep medications contribute to a substantial portion of the market, offering potential relief for individuals suffering from insomnia and other sleep disorders, thus underscoring a growing trend toward pharmaceutical interventions as part of sleep management strategies. 

Another pivotal aspect of the Product segment is sleep apnea devices, which have gained prominence due to the rising prevalence rates of sleep apnea disorders in France. The necessity for effective treatment options has led to advancements in technology, making these devices increasingly user-friendly and efficient.Additionally, the category of Others’ includes a range of emerging products like sleep tracking devices and relaxation apps, which cater to a modern consumer base looking for holistic approaches to sleep improvement.

The France Sleep Aids Market is supported by a backdrop of government initiatives promoting awareness of sleep disorders and their implications on health, thereby fostering a conducive environment for market growth. 

As consumers become more informed about sleep health, the demand for diverse and effective products within the segment is likely to expand further, shaping the future landscape of the industry.Challenges in this segment may include regulatory hurdles related to medications and devices, as well as maintaining consumer trust amidst a variety of product claims and efficacy. Opportunities abound as ongoing research uncovers new insights into sleep science, paving the way for innovative solutions tailored to meet the diverse needs of consumers.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Sleep Aids Market Sleep-Disorder Insights**

The Sleep-Disorder segment within the France Sleep Aids Market represents a crucial area of focus as it addresses various conditions affecting the quality of sleep for millions. Disorders such as Insomnia and Sleep Apnea significantly impact daily functioning and overall health, making effective treatment essential for a substantial portion of the population.

In France, the prevalence of Insomnia continues to rise, driven by factors such as increased work stress and lifestyle changes, leading to a growing demand for innovative treatment solutions.Sleep Apnea, another critical disorder, has gained attention due to its association with various health complications, including cardiovascular issues, which has prompted both public awareness campaigns and advancements in therapeutic devices. 

Restless Legs Syndrome and Narcolepsy, though less common, still hold considerable importance as they disrupt sleep in unique ways, necessitating dedicated treatment approaches. Additionally, Sleep Walking and other less recognized sleep disorders contribute to the overall complexity of sleep health, emphasizing the need for comprehensive care strategies.The diversity of this segment highlights both the challenges faced by individuals with these disorders and the opportunities for market players to develop tailored solutions that enhance sleep quality and overall wellness.

**France Sleep Aids Market Key Players and Competitive Insights**

The France Sleep Aids Market is characterized by a competitive landscape that includes various players offering a range of products designed to enhance sleep quality and address insomnia-related issues. The demand for sleep aids in the country has steadily increased, driven by rising awareness of sleep disorders and the importance of sleep for overall health. This market comprises both pharmaceutical solutions and natural supplements, leading to diverse offerings aimed at different consumer segments. 

With the presence of multinational corporations and niche service providers, the competitive dynamics in the France Sleep Aids Market reflect the need for innovative solutions tailored to consumer preferences, regulatory considerations, and an increasing focus on well-being.GlaxoSmithKline stands as a significant player in the France Sleep Aids Market, leveraging its strong brand recognition and wide-ranging product portfolio. The company has established itself by offering a variety of proven sleep medications that cater to different sleep disorders, including insomnia.

With a robust research and development framework, GlaxoSmithKline continually enhances its formulations to meet evolving consumer needs and comply with stringent regulatory standards. 

The firm's commitment to quality and efficacy has earned it a loyal customer base in France. Additionally, its extensive distribution networks ensure that GlaxoSmithKline's products are readily available across pharmacies and healthcare institutions, further solidifying its competitive position.Elysium Health, while a relatively newer entrant in the France Sleep Aids Market, has differentiated itself through its focus on scientifically backed nutritional supplements aimed at enhancing sleep quality. The company's key offerings in this domain emphasize natural ingredients and innovative formulations, appealing to health-conscious consumers looking for alternatives to traditional pharmaceuticals. 

Elysium Health has actively sought partnerships with research institutions to validate its product efficacy, bolstering its market credibility. The firm has also made strategic decisions regarding mergers and acquisitions, enhancing its capabilities and expanding its reach within the French market. Through its commitment to quality and science-driven solutions, Elysium Health has positioned itself as a noteworthy competitor, appealing largely to a demographic interested in holistic approaches to sleep enhancement.

**Key Companies in the France Sleep Aids Market Include**

**France Sleep Aids Market Industry Developments**

The France Sleep Aids Market is experiencing notable developments, particularly with key companies actively shaping the landscape. GlaxoSmithKline and Johnson & Johnson are enhancing their product offerings, responding to the increasing consumer focus on natural sleep solutions, while companies like Elysium Health and Nestlé are investing in Research and Development to innovate their sleep aid formulations. Recently, Tempur Sealy announced a strategic partnership with Sleep Innovations aimed at creating advanced sleep technology solutions, further emphasizing the importance of quality sleep in consumer wellness.

In September 2023, Sanofi expanded its portfolio by acquiring a stake in a melatonin distributor to bolster its presence in the natural sleep aid segment. 

Market valuation for these companies has grown remarkably over the past few years; for example, the melatonin segment, largely driven by increasing insomnia rates in France, saw significant sales growth in 2022. Additionally, the rise of telehealth services post-pandemic has prompted ResMed to innovate its products for remote monitoring of sleep apnea, reflecting a shift towards integrated health solutions. Meanwhile, Bristol-Myers Squibb remains committed to its holistic approach, addressing both mental health and sleep challenges through new therapeutic options.

**France Sleep Aids Market Segmentation Insights**

## Market Drivers

### Aging Population and Sleep Needs

France's aging population is another significant driver influencing the sleep aids market. As the demographic shifts, with a growing number of individuals aged 65 and older, the prevalence of sleep disorders tends to increase. Older adults often face challenges such as insomnia and restless leg syndrome, which can severely affect their quality of life. Reports suggest that nearly 50% of older adults in France experience sleep disturbances, leading to a heightened demand for sleep aids tailored to this demographic. This trend indicates a potential market expansion, as manufacturers may focus on developing products specifically designed for older consumers. Additionally, healthcare providers are likely to recommend sleep aids more frequently to this age group, further propelling the market's growth. Thus, the aging population presents a unique opportunity for the sleep aids market to cater to the specific needs of older adults.

### Growing Awareness of Sleep Disorders

The increasing awareness of sleep disorders among the French population is a pivotal driver for the sleep aids market. As more individuals recognize the impact of conditions such as insomnia and sleep apnea on overall health, the demand for effective sleep aids is likely to rise. Recent studies indicate that approximately 30% of adults in France experience sleep-related issues, prompting healthcare professionals to recommend various sleep aids. This heightened awareness is fostering a culture where seeking solutions for sleep disturbances is becoming normalized, thereby expanding the market. Furthermore, educational campaigns by health organizations are contributing to this trend, emphasizing the importance of quality sleep and the role of sleep aids in achieving it. Consequently, poised for growth as consumers increasingly seek remedies to enhance sleep quality..

### Rising Stress Levels and Sleep Disruption

The escalating stress levels among the French population are contributing to an increased demand for sleep aids. Factors such as work-related pressures, economic uncertainties, and lifestyle changes are leading to heightened anxiety and sleep disruption. Recent surveys indicate that over 40% of French adults report experiencing stress that negatively impacts their sleep quality. This trend suggests a growing reliance on sleep aids as individuals seek relief from stress-induced insomnia. The sleep aids market is likely to benefit from this phenomenon, as consumers turn to both over-the-counter and prescription solutions to manage their sleep issues. Furthermore, the integration of stress management techniques alongside sleep aids may enhance their effectiveness, creating a synergistic approach to improving sleep quality. As stress continues to be a prevalent issue, the sleep aids market is expected to expand in response to these changing consumer needs.

### Increased Availability of Sleep Aid Products

The enhanced availability of sleep aid products in France is a crucial driver for the sleep aids market. Retailers, both online and brick-and-mortar, are expanding their offerings to include a diverse range of sleep aids, from herbal supplements to advanced sleep technology devices. This trend is supported by the growing e-commerce sector, which allows consumers to access a wider variety of products conveniently. Data indicates that online sales of sleep aids have surged by approximately 25% in the past year, reflecting a shift in consumer purchasing behavior. Additionally, pharmacies and health stores are increasingly stocking sleep aids, making them more accessible to the general public. This increased availability not only caters to the rising demand but also encourages consumers to explore different options, thereby driving market growth. As product diversity continues to expand, the sleep aids market is likely to see sustained interest and investment.

### Influence of Lifestyle Changes on Sleep Patterns

Lifestyle changes among the French population are significantly impacting sleep patterns, thereby driving the sleep aids market. Factors such as increased screen time, irregular work hours, and dietary habits are contributing to a decline in sleep quality. Research indicates that nearly 35% of French adults report poor sleep due to lifestyle choices, prompting a search for effective sleep aids. This trend suggests that consumers are becoming more proactive in addressing their sleep issues, leading to a greater acceptance of sleep aids as part of their nightly routine. Moreover, the rise of wellness culture is encouraging individuals to prioritize sleep health, further fueling the demand for sleep aids. As lifestyle-related sleep disturbances persist, the sleep aids market is expected to grow, with manufacturers likely to innovate and adapt their products to meet the evolving needs of consumers.

## Future Outlook

The [Sleep Aids Market](https://www.marketresearchfuture.com/reports/sleep-aids-market-11738) in France is projected to grow at a 7.18% CAGR from 2025 to 2035, driven by increasing consumer awareness and technological advancements.

**New opportunities:**

- Development of subscription-based sleep aid products Integration of AI-driven sleep tracking technologies Expansion of e-commerce platforms for sleep aids

By 2035, the market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product: Mattresses & Pillows (Largest) vs. Sleep Apnea Devices (Fastest-Growing)

In the France sleep aids market, the distribution of market share among the product segments reveals that mattresses and pillows hold the largest share, appealing to a broad consumer base seeking comfort and support during sleep. Medications and sleep apnea devices follow, each serving specific needs that contribute to a diverse market landscape. Others include various niche products catering to specialized demands, thereby enriching the segment even further.

As consumer awareness about sleep health increases, the growth trends show a marked rise in the adoption of sleep apnea devices, making it the fastest-growing segment. The driving forces include technological advancements, greater accessibility to healthcare solutions, and increasing diagnoses of sleep disorders that push for innovative treatments. Additionally, the sustained popularity of mattresses and pillows continues, ensuring a steady market presence as consumers prioritize quality sleep for enhanced well-being.

Mattresses & Pillows: Dominant vs. Sleep Apnea Devices: Emerging

Mattresses and pillows dominate the product segment of the France sleep aids market, driven by a wide variety of material innovations and ergonomic designs that appeal to consumers seeking optimized sleep experiences. This segment thrives on the continuous introduction of new technologies, such as memory foam and adjustable beds, catering to diverse sleeping preferences. Conversely, sleep apnea devices have emerged as a rapidly growing segment thanks to increasing awareness and diagnosis of sleep apnea among the population. This growth is supported by advancements in device technology, such as more compact, user-friendly CPAP (Continuous Positive Airway Pressure) machines and improvements in comfort, which have made these devices more appealing. The competition in this sector is intensifying as manufacturers strive to introduce smarter, more effective solutions that cater to evolving consumer needs.

### By Sleep Disorder: Insomnia (Largest) vs. Sleep Apnea (Fastest-Growing)

In the France sleep aids market, insomnia presents the largest share among sleep disorders, with a significant portion of consumers seeking treatment options to combat this prevalent issue. Following closely, sleep apnea has rapidly gained attention, reflecting a growing awareness and diagnosis of the condition, as well as an increasing number of patients looking for effective solutions.

Insomnia: Dominant vs. Sleep Apnea: Emerging

Insomnia remains the dominant disorder in the France sleep aids market, characterized by difficulty falling or staying asleep, affecting millions of individuals and driving the demand for various therapeutic products. On the other hand, sleep apnea, an emerging segment, is recognized for its serious implications and is gaining traction as more patients are diagnosed. Factors such as technological advancements in diagnostic tools and the rising health consciousness among consumers contribute to the growth of this segment, emphasizing the need for innovative treatment options.

## Competitive Benchmarking

The sleep aids market in France is characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding sleep health and the rising prevalence of sleep disorders. Key players such as Sanofi (FR), Pfizer Inc (US), and Reckitt Benckiser Group plc (GB) are actively shaping the market through strategic initiatives. Sanofi (FR) focuses on innovation in over-the-counter sleep aids, leveraging its strong pharmaceutical background to develop products that cater to diverse consumer needs. Meanwhile, Pfizer Inc (US) emphasizes partnerships with healthcare providers to enhance product accessibility and consumer education, thereby positioning itself as a trusted leader in the sector. Reckitt Benckiser Group plc (GB) adopts a consumer-centric approach, investing in marketing campaigns that highlight the importance of sleep hygiene, which collectively influences the competitive dynamics of the market.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure of the market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Sanofi (FR) and Reckitt Benckiser Group plc (GB) suggests a trend towards consolidation, as these firms seek to leverage their strengths to capture a larger share of the growing market.

In October  Sanofi (FR) announced the launch of a new line of sleep aids specifically designed for children, which aims to address the increasing concerns of parents regarding sleep quality in younger demographics. This strategic move not only diversifies Sanofi's product portfolio but also taps into an underserved market segment, potentially enhancing its competitive edge. The introduction of child-friendly formulations may also foster brand loyalty among families, positioning Sanofi as a go-to provider for sleep solutions.

In September  Reckitt Benckiser Group plc (GB) unveiled a digital platform aimed at educating consumers about sleep health and promoting its sleep aid products. This initiative reflects a growing trend towards digitalization in the market, as companies recognize the importance of engaging consumers through online channels. By providing valuable information and resources, Reckitt Benckiser Group plc (GB) enhances its brand visibility and establishes itself as a thought leader in sleep health, which could lead to increased sales and market share.

In August  Pfizer Inc (US) entered into a strategic partnership with a leading telehealth provider to offer virtual consultations for sleep disorders. This collaboration is indicative of the increasing integration of technology in healthcare, allowing Pfizer to reach a broader audience and provide tailored solutions for sleep issues. By leveraging telehealth services, Pfizer Inc (US) not only enhances its service offerings but also positions itself at the forefront of the evolving healthcare landscape.

As of November  current trends in the sleep aids market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and enhancing consumer engagement. The evolution of competitive differentiation appears to be moving away from price-based strategies towards a focus on technological advancements, product innovation, and supply chain reliability. This shift suggests that companies that prioritize these aspects may be better positioned to thrive in the increasingly competitive environment.

## Recent News & Developments

The France Sleep Aids Market is experiencing notable developments, particularly with key companies actively shaping the landscape. GlaxoSmithKline and Johnson & Johnson are enhancing their product offerings, responding to the increasing consumer focus on natural sleep solutions, while companies like Elysium Health and Nestlé are investing in Research and Development to innovate their sleep aid formulations. Recently, Tempur Sealy announced a strategic partnership with Sleep Innovations aimed at creating advanced sleep technology solutions, further emphasizing the importance of quality sleep in consumer wellness.

In September 2023, Sanofi expanded its portfolio by acquiring a stake in a melatonin distributor to bolster its presence in the natural sleep aid segment. 

Market valuation for these companies has grown remarkably over the past few years; for example, the melatonin segment, largely driven by increasing insomnia rates in France, saw significant sales growth in 2022. Additionally, the rise of telehealth services post-pandemic has prompted ResMed to innovate its products for remote monitoring of sleep apnea, reflecting a shift towards integrated health solutions. Meanwhile, Bristol-Myers Squibb remains committed to its holistic approach, addressing both mental health and sleep challenges through new therapeutic options.

## Report Scope

| MARKET SIZE 2024 | 2592.94(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 2779.11(USD Million) |
| MARKET SIZE 2035 | 5558.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.18% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Pfizer Inc (US), Johnson & Johnson (US), Sanofi (FR), Reckitt Benckiser Group plc (GB), Procter & Gamble Co (US), Sleep Number Corporation (US), ResMed Inc (US), Haleon plc (GB) |
| Segments Covered | Product, Sleep Disorder |
| Key Market Opportunities | Integration of digital health solutions enhances consumer engagement in the sleep aids market. |
| Key Market Dynamics | Rising consumer demand for natural sleep aids drives innovation and competition in the sleep aids market. |
| Countries Covered | France |

## Frequently Asked Questions

**Q: What was the overall market valuation of the sleep aids market in 2024?**
A: The overall market valuation was $2592.94 Million in 2024.

**Q: What is the projected market valuation for the sleep aids market by 2035?**
A: The projected market valuation for 2035 is $5558.0 Million.

**Q: What is the expected CAGR for the sleep aids market during the forecast period 2025 - 2035?**
A: The expected CAGR for the sleep aids market during the forecast period 2025 - 2035 is 7.18%.

**Q: Which product segment had the highest valuation in 2024?**
A: In 2024, the Medications segment had the highest valuation at $900.0 Million.

**Q: What is the valuation range for Sleep Apnea Devices from 2024 to 2035?**
A: The valuation for Sleep Apnea Devices ranges from $600.0 Million to $1200.0 Million.

**Q: Which company is a key player in the sleep aids market?**
A: Key players in the market include Pfizer Inc, Johnson & Johnson, and Sanofi.

**Q: What was the valuation of the Restless Legs Syndrome segment in 2024?**
A: The valuation of the Restless Legs Syndrome segment was $300.0 Million in 2024.

**Q: What is the projected valuation for the Others segment by 2035?**
A: The projected valuation for the Others segment is expected to reach $858.0 Million by 2035.

**Q: How does the valuation of Insomnia compare to Sleep Apnea in 2024?**
A: In 2024, the Insomnia segment was valued at $600.0 Million, while Sleep Apnea was valued at $800.0 Million.

**Q: What is the expected growth trend for the sleep aids market in the coming years?**
A: The sleep aids market is likely to experience robust growth, driven by an expected CAGR of 7.18% from 2025 to 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/france-sleep-aids-market-52026*